Katrina Goddard, PhD

Senior Investigator
Katrina Goddard

Katrina Goddard, PhD, is a genetic epidemiologist whose research focuses on public health genomics and the translation of genetic testing into practice. She joined the Center for Health Research in 2007. Dr. Goddard is the co-Principal Investigator on a large comparative effectiveness research project in genomic and personalized medicine for colon cancer. In addition, she is the Director of the Oregon Clinical Translational Research Institute’s Biorepository, which uses discarded clinical blood specimens for genetic research, and she is leading efforts to develop the NW Biobank.

She has worked on identifying genetic risk factors for various diseases, such as prostate cancer, esophageal cancer, Alzheimer’s disease, and others, and has been involved in the evaluation of commercial genetic-testing. She worked on a multicenter study to map genes for Fuchs’ dystrophy, and served as Principal Investigator of the Tools for Analysis of Whole-Genome Association in Cystic Fibrosis project. Dr. Goddard recently completed a one year mid-career fellowship in the National Office of Public Health Genomics under the direction of Muin Khoury, which was jointly sponsored by the Centers for Disease Control and the American Society of Human Genetics.

She received her PhD in Biostatistics from the University of Washington in 1999, and a BS in Molecular Biology from the University of Wisconsin-Madison. Prior to her appointment as a Senior Investigator at the Center for Health Research, Dr. Goddard was on the faculty at Case Western Reserve University in the Division of Genetic & Molecular Epidemiology, directed by Dr. Robert Elston. At Case Western, she was involved in several large-scale gene-discovery projects, and was the Associate Director of the Human Genetic Analysis Resource, which produces the S.A.G.E. software package.

E-mail: Katrina.AB.Goddard@kpchr.org

Recent Publications:

Behl AS, Goddard KA, Flottemesch TJ, Veenstra D, Meenan RT, Lin JS, Maciosek MV. Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer. Journal of the National Cancer Institute 2012 Dec 5; 104(23):1785-95. [Epub 2012 Nov 28]   Full text
Betsou F, Gunter E, Clements J, Desouza Y, Goddard KA, Guadagni F, Yan W, Skubitz A, Somiari S, Yeadon T, Chuaqui R. Identification of evidence-based biospecimen quality-control tools: A report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group. The Journal of Molecular Diagnostics 2012 Nov 26. [Epub 2012 Nov 26]   PubMed abstract
Bowles EJ, Wellman R, Fiegelson HS, Onitilo AA, Freedman AN, Delate T, Allen LA, Nekhlyudov L, Goddard KA, Davis R, Habel LA, Yood MU, McCarty C, Magid DJ, Wagner EH; Pharmacovigilance Study Team. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: A retrospective cohort study. Journal of the National Cancer Institute 2012 Sep 5;104(17):1293-305. PMCID:PMC3433392   Full text
Cross D, Rahm A, Le A, Webster J, Potosky A, Feigelson H, Alexander G, Pawolski P, Williams A, Daida Y, Honda S, Onitilo A, McCarty C, Goddard K.PS1-08: Lynch Syndrome screening patterns in colorectal cancer patients in a large multi-institutional cohort. Clinical Medical Research 2012 Aug; 10(3):146. PMC3421367    Full text
Delate T, Bowles EA, Pardee R, Wellman R, Habel L, Yood MU, Nekhlyudov L, Goddard, K, Davis R, McCarty C, Onitilo A, Feigelson HS, Freml J, Wagner E. Validity of eight integrated healthcare delivery organizations’ administrative clinical data to capture breast cancer chemotherapy exposure. Cancer Epidemiology, Biomarkers & Prevention 2012 Apr;21(4):673-80. [Epub 2012 Feb 15] PMCID: PMC3319397 [Available on 2013/4/1]    Full text
Deverka PA, Schully SD, Ishibe N, Carlson JJ, Freedman A, Goddard KA, Khoury MJ, Ramsey SD. Stakeholder assessment of the evidence for cancer genomic tests: Insights from three case studies. Genet Med 2012 Jul;14(7):656-62.    PubMed abstract
El-Meanawy A, Schelling JR, Iyengar SK, Hayden P, Barathan S, Goddard K, Pozuelo F, Elashi E, Nair V, Kretzler M, Sedor JR. Identification of nephropathy candidate genes by comparing sclerosis-prone and sclerosis-resistant mouse strain kidney transcriptomes. BMC Nephrology 2012 Jul 19;13(1):61. [Epub ahead of print] PMC3502501   Full text
Feigelson HS, Goddard KAB, Johnson MA, Funk KC, Rahm AK, Kauffman TL, Chitale DA, Le Marchand LL, Richards CS. Reliability of KRAS mutation testing in metastaticcolorectal cancer patients across five laboratories. BMC Research Notes 2012 2012 Apr 25; 5(1):196. PMCID: PMC3441241   Full text
Goddard KA, Aiello Bowles EJ, Spencer Feigelson H, Habel LA, Alford SH, McCarty CA, Nekhlyudov L, Onitilo AA, Rahm AK, Webster JA. Utilization of HER2 genetic testing in a multi-institutional observational study. American Journal of Managed Care 2012 Nov; 18(11):704-12. NIHMSID # 436570   Full text
Goddard KAB, Knaus WA, Whitlock EP, Lyman GH, Feigelson HS, Schully S, Ramsey S, Tunis S, Freedman AN, Khoury MJ, Veenstra DL. Building the evidence base for decision making in cancer genomics using comparative effectiveness research. Genetics in Medicine 2012 Jul; 14(7):633-42. [Epub 2012 Apr 19]    Full text


More Publications »
Kaiser Permanente